Galpha13 mediates activation of the cytosolic phospholipase A2alpha through fine regulation of ERK phosphorylation

Cell Signal. 2006 Dec;18(12):2200-8. doi: 10.1016/j.cellsig.2006.05.003. Epub 2006 May 20.

Abstract

Heterotrimeric GTP-binding (G) proteins transduce hormone-induced signals to their effector enzymes, which include several phospholipases. In particular, the G(o)/G(i) and G(q) protein families have been shown to couple signaling to phospholipase A(2) (PLA(2)), phospholipase C, and phospholipase D, while the G(12)/G(13) family has been linked to the activation of small GTPases of the Rho family, and hence, to phospholipase D activation. Here, we demonstrate that in CHO cells, the G(12)/G(13) family is also able to activate cPLA(2)alpha, through the activation of RhoA and, subsequently, ERK1/2. Hormone-induced arachidonic acid release increased as a consequence of Galpha(13) overexpression, and was inhibited through inhibition of Galpha(13) signaling. The Galpha(13)-mediated cPLA(2)alpha activation was inhibited by pharmacological blockade of ERK1/2 with either U0126 or PD98059, and by RhoA inactivation with C3 toxin or a dominant-negative RhoA (N19RhoA), and was stimulated by the serine-threonine phosphatase inhibitor calyculin A. Our data thus identify a pathway of cPLA(2)alpha regulation that is initiated by thrombin and purinergic receptor activation, and that signals through Galpha(13), RhoA and ERK1/2, with the involvement of a calyculin-sensitive phosphatase.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Arachidonic Acid / metabolism
  • Butadienes / pharmacology
  • CHO Cells
  • Cricetinae
  • Cricetulus
  • Cytosol / enzymology
  • Enzyme Activation
  • Enzyme Inhibitors / pharmacology
  • GTP-Binding Protein alpha Subunits, G12-G13 / genetics
  • GTP-Binding Protein alpha Subunits, G12-G13 / metabolism*
  • Group IV Phospholipases A2
  • Imidazoles / pharmacology
  • Marine Toxins
  • Mitogen-Activated Protein Kinase 1 / antagonists & inhibitors
  • Mitogen-Activated Protein Kinase 1 / metabolism
  • Mitogen-Activated Protein Kinase 3 / antagonists & inhibitors
  • Mitogen-Activated Protein Kinase 3 / metabolism
  • Mitogen-Activated Protein Kinases / antagonists & inhibitors
  • Mitogen-Activated Protein Kinases / metabolism*
  • Mutation / genetics
  • Nitriles / pharmacology
  • Oxazoles / pharmacology
  • Phospholipases A / antagonists & inhibitors
  • Phospholipases A / metabolism*
  • Phosphoric Monoester Hydrolases / antagonists & inhibitors
  • Phosphoric Monoester Hydrolases / metabolism
  • Phosphorylation
  • Pyridines / pharmacology
  • Pyrrolidines / pharmacology
  • Transfection
  • rhoA GTP-Binding Protein / metabolism

Substances

  • Butadienes
  • Enzyme Inhibitors
  • Imidazoles
  • Marine Toxins
  • Nitriles
  • Oxazoles
  • Pyridines
  • Pyrrolidines
  • U 0126
  • pyrrophenone
  • Arachidonic Acid
  • calyculin A
  • Mitogen-Activated Protein Kinase 1
  • Mitogen-Activated Protein Kinase 3
  • Mitogen-Activated Protein Kinases
  • Phospholipases A
  • Group IV Phospholipases A2
  • Phosphoric Monoester Hydrolases
  • GTP-Binding Protein alpha Subunits, G12-G13
  • rhoA GTP-Binding Protein
  • SB 203580